Preventing Cognitive Decline in Black Individuals With Mild Cognitive Impairment: A Randomized Clinical Trial.

Abstract:

Importance:Mild cognitive impairment (MCI) is a transition state between normal cognitive aging and dementia that increases the risk for progressive cognitive decline. Preventing cognitive decline is a public health priority. Objective:To determine whether behavioral activation prevents cognitive and functional decline over 2 years in black individuals with MCI. Design, Setting, and Participants:Single-center, single-masked, attention-controlled randomized clinical trial. Participants were enrolled from June 21, 2011, to October 3, 2014, and follow-up ended December 13, 2016. Community-based recruitment and treatment of black individuals older than 65 years with amnestic MCI. Volunteer sample of 1390 persons with memory complaints were screened. Overall, 536 individuals had baseline assessment, and 315 (58.8%) were ineligible, most often owing to normal cognition (205 of 315 [65%]) or dementia (59 of 315 [18.7%]); 221 fully eligible participants were randomized. Analyses were intention to treat. Interventions:Participants were randomized to behavioral activation, which aimed to increase cognitive, physical, and social activity (111 [50.2%]), or supportive therapy, an attention control treatment (110 [49.8%]). Main Outcomes and Measures:The prespecified primary outcome was a decline of 6 or more recalled words on the total recall score of the Hopkins Verbal Learning Test-Revised assessed at 6, 12, 18, and 24 months. The secondary outcome was functional decline. Results:Of 221 randomized participants (mean [SD] age, 75.8 [7.0] years, 175 women [79%]), 77 behavioral activation participants (69.4%) and 87 supportive therapy participants (79.1%) had 2-year outcome assessments. After baseline, behavioral activation participants engaged in significantly more cognitive activities than supportive therapy participants. The 2-year incidence of memory decline was 1.2% (95% CI, 0.2-6.4) for behavioral activation vs 9.3% (95% CI, 5.30-16.4) for supportive therapy (relative risk, 0.12; 95% CI, 0.02-0.74; P = .02). Behavioral activation was associated with stable everyday function, whereas supportive therapy was associated with decline (difference in slopes, 2.71; 95% CI, 0.12-5.30; P = .04). Rates of serious adverse events for behavioral activation and supportive therapy, respectively, were: falls (14 [13%] vs 28 [25%]), emergency department visits (24 [22%] vs 24 [22%]), hospitalizations (36 [32%] vs 31 [28%]), and deaths (7 [5%] vs 3 [4%]). Conclusions and Relevance:Behavioral activation prevented cognitive and functional decline, but this finding requires further investigation. Black individuals have almost twice the rate of dementia as white individuals; behavioral activation may reduce this health disparity. Trial Registration:ClinicalTrials.gov Identifier: NCT01299766.

journal_name

JAMA Neurol

journal_title

JAMA neurology

authors

Rovner BW,Casten RJ,Hegel MT,Leiby B

doi

10.1001/jamaneurol.2018.2513

subject

Has Abstract

pub_date

2018-12-01 00:00:00

pages

1487-1493

issue

12

eissn

2168-6149

issn

2168-6157

pii

2698824

journal_volume

75

pub_type

杂志文章,随机对照试验
  • Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.

    abstract:Importance:The safety and efficacy of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage who present with systolic blood pressure greater than 220 mm Hg appears to be unknown. Objective:To evaluate the differential outcomes of intensive (goal, 110-139 mm Hg) vs standard (goal, 140-17...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2020.3075

    authors: Qureshi AI,Huang W,Lobanova I,Barsan WG,Hanley DF,Hsu CY,Lin CL,Silbergleit R,Steiner T,Suarez JI,Toyoda K,Yamamoto H,for ATACH-II trial investigators.

    更新日期:2020-09-08 00:00:00

  • Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.

    abstract:IMPORTANCE:There is a deficit of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with neuropathologically confirmed Alzheimer dementia. However, whether this deficit is associated with the earlier stages of Alzheimer disease (AD) is unknown. This study was conducted to clarify the association bet...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2014.3625

    authors: Han P,Caselli RJ,Baxter L,Serrano G,Yin J,Beach TG,Reiman EM,Shi J

    更新日期:2015-03-01 00:00:00

  • Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome: The International Tourette Syndrome Deep Brain Stimulation Public Database and Registry.

    abstract:Importance:Collective evidence has strongly suggested that deep brain stimulation (DBS) is a promising therapy for Tourette syndrome. Objective:To assess the efficacy and safety of DBS in a multinational cohort of patients with Tourette syndrome. Design, Setting, and Participants:The prospective International Deep Br...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2017.4317

    authors: Martinez-Ramirez D,Jimenez-Shahed J,Leckman JF,Porta M,Servello D,Meng FG,Kuhn J,Huys D,Baldermann JC,Foltynie T,Hariz MI,Joyce EM,Zrinzo L,Kefalopoulou Z,Silburn P,Coyne T,Mogilner AY,Pourfar MH,Khandhar SM,Auyeung

    更新日期:2018-03-01 00:00:00

  • Restless genital syndrome in Parkinson disease.

    abstract:IMPORTANCE:Symptoms in the genital region, such as pain, discomfort, tingling, and burning sensations, have rarely been reported in Parkinson disease (PD), and the previous cases were attributed to nonmotor off symptoms. We report a patient with PD and severe genital discomfort unrelated to motor fluctuations but compa...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2014.1326

    authors: Aquino CC,Mestre T,Lang AE

    更新日期:2014-12-01 00:00:00

  • Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study.

    abstract:IMPORTANCE:Epidemiological data on hereditary cerebellar ataxia (HCA) and hereditary spastic paraplegia (HSP) are scarce. OBJECTIVE:To present the prevalence and distribution of HCA and HSP in Portugal. DESIGN AND SETTING:Population-based, nationwide, systematic survey, from January 1, 1994, through April 15, 2004, i...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.1707

    authors: Coutinho P,Ruano L,Loureiro JL,Cruz VT,Barros J,Tuna A,Barbot C,Guimarães J,Alonso I,Silveira I,Sequeiros J,Marques Neves J,Serrano P,Silva MC

    更新日期:2013-06-01 00:00:00

  • Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.

    abstract:Importance:The utility of plasma total tau level as a prognostic marker for cognitive decline and dementia is not well understood. Objectives:To determine (1) the association between plasma total tau level, cognitive decline, and risk of mild cognitive impairment (MCI) and dementia; (2) whether this association differ...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2017.1359

    authors: Mielke MM,Hagen CE,Wennberg AMV,Airey DC,Savica R,Knopman DS,Machulda MM,Roberts RO,Jack CR Jr,Petersen RC,Dage JL

    更新日期:2017-09-01 00:00:00

  • Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome: A Systematic Review and Meta-analysis.

    abstract:Importance:Spontaneous intracranial hypotension (SIH) is a highly disabling but often misdiagnosed disorder. The best management options for patients with SIH are still uncertain. Objective:To provide an objective summary of the available evidence on the clinical presentation, investigations findings, and treatment ou...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2020.4799

    authors: D'Antona L,Jaime Merchan MA,Vassiliou A,Watkins LD,Davagnanam I,Toma AK,Matharu MS

    更新日期:2021-01-04 00:00:00

  • Endovascular Thrombectomy as a Means to Improve Survival in Acute Ischemic Stroke: A Meta-analysis.

    abstract:Importance:Although endovascular thrombectomy (EVT) in acute ischemic stroke is recommended by guidelines to improve functional recovery, thus far there are insufficient data on its association with mortality. Objective:To identify guideline-relevant trials of EVT vs medical therapy reporting 90-day mortality and perf...

    journal_title:JAMA neurology

    pub_type: 杂志文章,meta分析

    doi:10.1001/jamaneurol.2019.0525

    authors: Lin Y,Schulze V,Brockmeyer M,Parco C,Karathanos A,Heinen Y,Gliem M,Hartung HP,Antoch G,Jander S,Turowski B,Perings S,Kelm M,Wolff G

    更新日期:2019-07-01 00:00:00

  • Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum.

    abstract:IMPORTANCE:Documentation of muscle pathology compatible with targeting of sarcolemmal aquaporin-4 (AQP4) by complement-activating IgG implies involvement of organs beyond the central nervous system in neuromyelitis optica spectrum disorders. OBSERVATIONS:We report on a 51-year-old woman who had relapsing optic neuriti...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2014.775

    authors: Guo Y,Lennon VA,Popescu BF,Grouse CK,Topel J,Milone M,Lassmann H,Parisi JE,Pittock SJ,Stefoski D,Balabanov R,Lucchinetti CF

    更新日期:2014-08-01 00:00:00

  • Natalizumab therapy for highly active pediatric multiple sclerosis.

    abstract:IMPORTANCE:Given the high frequency of failure of first-line therapies, there is an urgent need for second-line treatment strategies for pediatric patients with multiple sclerosis (MS). OBJECTIVE:To report the use of natalizumab in pediatric MS. Natalizumab, a humanized monoclonal antibody targeting α4 integrin, is ef...

    journal_title:JAMA neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamaneurol.2013.923

    authors: Kornek B,Aboul-Enein F,Rostasy K,Milos RI,Steiner I,Penzien J,Hellwig K,Pitarokoili K,Storm van's Gravesande K,Karenfort M,Blaschek A,Meyer A,Seidl R,Debelic D,Vass K,Prayer D,Kristoferitsch W,Bayas A

    更新日期:2013-04-01 00:00:00

  • Emerging therapies for glioblastoma.

    abstract:IMPORTANCE:Glioblastoma is the most common primary malignant brain tumor, but despite multimodal treatment with surgery, radiotherapy, and temozolomide chemotherapy, the prognosis is poor, with a median survival of 16 to 19 months and poor quality of life throughout the disease course. New treatments are needed. EVIDE...

    journal_title:JAMA neurology

    pub_type: 杂志文章,评审

    doi:10.1001/jamaneurol.2014.1701

    authors: Thomas AA,Brennan CW,DeAngelis LM,Omuro AM

    更新日期:2014-11-01 00:00:00

  • The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.

    abstract:IMPORTANCE:β-Amyloid (Aβ) deposition and vascular brain injury (VBI) frequently co-occur and are both associated with cognitive decline in aging. Determining whether a direct relationship exists between them has been challenging. We sought to understand VBI's influence on cognition and clinical impairment, separate fro...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/2013.jamaneurol.405

    authors: Marchant NL,Reed BR,Sanossian N,Madison CM,Kriger S,Dhada R,Mack WJ,DeCarli C,Weiner MW,Mungas DM,Chui HC,Jagust WJ

    更新日期:2013-04-01 00:00:00

  • Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.

    abstract:IMPORTANCE:Mild strokes have been poorly represented in thrombolytic trials and only a few series have reported outcomes after treatment with intravenous (IV) recombinant tissue plasminogen activator (rtPA) after mild stroke. OBJECTIVE:To report treatment complications and short-term outcomes in patients with mild str...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2014.4354

    authors: Romano JG,Smith EE,Liang L,Gardener H,Camp S,Shuey L,Cook A,Campo-Bustillo I,Khatri P,Bhatt DL,Fonarow GC,Sacco RL,Schwamm LH

    更新日期:2015-04-01 00:00:00

  • Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile.

    abstract:IMPORTANCE:While advances have been made in characterizing the C9ORF72 clinical phenotype, the hallmark features that discriminate between carriers and noncarriers remain unclear. OBJECTIVES:To determine the frequency of the C9ORF72 mutation in a frontotemporal dementia (FTD) cohort and to define the clinical, neurops...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.6002

    authors: Devenney E,Hornberger M,Irish M,Mioshi E,Burrell J,Tan R,Kiernan MC,Hodges JR

    更新日期:2014-03-01 00:00:00

  • Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

    abstract:IMPORTANCE:The extent to which large-caliber axonal degeneration contributes to Alzheimer disease (AD) progression is unknown. Cerebrospinal fluid (CSF) neurofilament light (NFL) concentration is a general marker of damage to large-caliber myelinated axons. OBJECTIVE:To test whether CSF NFL concentration is associated...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2015.3037

    authors: Zetterberg H,Skillbäck T,Mattsson N,Trojanowski JQ,Portelius E,Shaw LM,Weiner MW,Blennow K,Alzheimer’s Disease Neuroimaging Initiative.

    更新日期:2016-01-01 00:00:00

  • Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.

    abstract:IMPORTANCE:Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disorder of the central nervous system. Recently, various immunosuppressant medications were introduced as therapeutic options for preventing relapse of NMOSD. However, our understanding of the effectiveness of mycophenolate mofetil...

    journal_title:JAMA neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1001/jamaneurol.2014.2057

    authors: Huh SY,Kim SH,Hyun JW,Joung AR,Park MS,Kim BJ,Kim HJ

    更新日期:2014-11-01 00:00:00

  • Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis.

    abstract:Importance:Cognitive impairment in multiple sclerosis (MS) can lead to reduced quality of life, social functioning, and employment. Few studies have investigated cognitive outcomes among patients with pediatric-onset MS (POMS) over the long term. Objective:To compare long-term information-processing efficiency between...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2019.1546

    authors: McKay KA,Manouchehrinia A,Berrigan L,Fisk JD,Olsson T,Hillert J

    更新日期:2019-06-17 00:00:00

  • Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

    abstract:IMPORTANCE:Aquaporin 4 antibody (AQP4-Ab)-negative patients with longitudinally extensive transverse myelitis (LETM) behave differently from those with AQP4-Ab. Aquaporin 4 antibody-negative neuromyelitis optica (NMO) is rare when good assays are used. OBJECTIVE:To assess if AQP4-Ab-negative patients with LETM share s...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.3890

    authors: Kitley J,Leite MI,Küker W,Quaghebeur G,George J,Waters P,Woodhall M,Vincent A,Palace J

    更新日期:2013-11-01 00:00:00

  • The growth and impact of Alzheimer disease centers as measured by social network analysis.

    abstract:IMPORTANCE:Alzheimer disease (AD) is a neurodegenerative disorder with no effective therapies. In 1984, the National Institute on Aging created the first 5 AD centers (ADCs) in an effort to coordinate research efforts into the pathology and treatment of the disease. Since that time, the ADC program has expanded to incl...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.6225

    authors: Hughes ME,Peeler J,Hogenesch JB,Trojanowski JQ

    更新日期:2014-04-01 00:00:00

  • Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom.

    abstract:Importance:Cardiovascular disease (CVD) risk has not been previously evaluated in a large matched cohort study in idiopathic intracranial hypertension (IIH). Objectives:To estimate the risk of composite cardiovascular events, heart failure, ischemic heart disease, stroke/transient ischemic attack (TIA), type 2 diabete...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2019.1812

    authors: Adderley NJ,Subramanian A,Nirantharakumar K,Yiangou A,Gokhale KM,Mollan SP,Sinclair AJ

    更新日期:2019-07-08 00:00:00

  • Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.

    abstract:IMPORTANCE:Voltage-gated potassium channel complex antibody (VGKCc-Ab) encephalitis is an immunotherapy-responsive syndrome usually associated with causative antibodies that target the leucine-rich, glioma inactivated 1 (LGI1) protein. Although it is expressed throughout the brain, LGI1 is not known to be expressed in ...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2014.1234

    authors: Naasan G,Irani SR,Bettcher BM,Geschwind MD,Gelfand JM

    更新日期:2014-10-01 00:00:00

  • Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury.

    abstract:Importance:The development and expansion of intracranial hematoma are associated with adverse outcomes. Use of tranexamic acid might limit intracranial hematoma formation, but its association with outcomes of severe traumatic brain injury (TBI) is unclear. Objective:To assess whether prehospital administration of tran...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2020.4596

    authors: Bossers SM,Loer SA,Bloemers FW,Den Hartog D,Van Lieshout EMM,Hoogerwerf N,van der Naalt J,Absalom AR,Peerdeman SM,Schwarte LA,Boer C,Schober P,BRAIN-PROTECT collaborators.

    更新日期:2020-12-07 00:00:00

  • Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease: The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study.

    abstract:IMPORTANCE:Gait and cognition have been related to mortality in population-based studies. This association is possibly mediated by cerebral small vessel disease (SVD), which has been associated with mortality as well. It is unknown which factors can predict mortality in individuals with SVD. Identification of high-risk...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2015.4560

    authors: van der Holst HM,van Uden IW,Tuladhar AM,de Laat KF,van Norden AG,Norris DG,van Dijk EJ,Rutten-Jacobs LC,de Leeuw FE

    更新日期:2016-04-01 00:00:00

  • Prevalence of Invalid Performance on Baseline Testing for Sport-Related Concussion by Age and Validity Indicator.

    abstract:Importance:Estimated base rates of invalid performance on baseline testing (base rates of failure) for the management of sport-related concussion range from 6.1% to 40.0%, depending on the validity indicator used. The instability of this key measure represents a challenge in the clinical interpretation of test results ...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2018.0031

    authors: Abeare CA,Messa I,Zuccato BG,Merker B,Erdodi L

    更新日期:2018-06-01 00:00:00

  • Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

    abstract:IMPORTANCE:The frequency and distribution of synucleinopathies and tauopathies manifesting with parkinsonism in the general population are poorly understood, thus affecting health care planning and research. OBJECTIVE:To investigate the incidence and distribution of specific types of parkinsonism and related proteinop...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.114

    authors: Savica R,Grossardt BR,Bower JH,Ahlskog JE,Rocca WA

    更新日期:2013-07-01 00:00:00

  • Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

    abstract:IMPORTANCE:Neurogranin (NGRN) seems to be a promising novel cerebrospinal fluid (CSF) biomarker for synaptic loss; however, clinical, and especially longitudinal, data are sparse. OBJECTIVE:To examine the utility of NGRN, with repeated CSF sampling, for diagnosis, prognosis, and monitoring of Alzheimer disease (AD). ...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2015.1867

    authors: Kester MI,Teunissen CE,Crimmins DL,Herries EM,Ladenson JH,Scheltens P,van der Flier WM,Morris JC,Holtzman DM,Fagan AM

    更新日期:2015-11-01 00:00:00

  • Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

    abstract:Importance:A neurophysiologic signature of the melanopsin-mediated persistent constriction phase of the pupillary light reflex may represent a surrogate biomarker for the integrity of the retinohypothalamic tract, with potential utility for investigating alterations in homeostatic mechanisms associated with brain disor...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2016.5131

    authors: Meltzer E,Sguigna PV,Subei A,Beh S,Kildebeck E,Conger D,Conger A,Lucero M,Frohman BS,Frohman AN,Saidha S,Galetta S,Calabresi PA,Rennaker R,Frohman TC,Kardon RH,Balcer LJ,Frohman EM

    更新日期:2017-05-01 00:00:00

  • Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers.

    abstract:IMPORTANCE:Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology in inflammatory CNS disorders like multiple sclerosis (MS). Multiparameter flow cytometry is used to characterize immunological alterations in the CSF of patient...

    journal_title:JAMA neurology

    pub_type: 杂志文章,评审

    doi:10.1001/jamaneurol.2014.395

    authors: Alvermann S,Hennig C,Stüve O,Wiendl H,Stangel M

    更新日期:2014-07-01 00:00:00

  • SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy.

    abstract:BACKGROUND:Therapies designed to decrease the level of SOD1 are currently in a clinical trial for patients with superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis (ALS). OBJECTIVE:To determine whether the SOD1 protein in cerebral spinal fluid (CSF) may be a pharmacodynamic marker for antisense o...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.593

    authors: Winer L,Srinivasan D,Chun S,Lacomis D,Jaffa M,Fagan A,Holtzman DM,Wancewicz E,Bennett CF,Bowser R,Cudkowicz M,Miller TM

    更新日期:2013-02-01 00:00:00

  • Does a positive Pittsburgh Compound B scan in a patient with dementia equal Alzheimer disease?

    abstract:IMPORTANCE:The clinical role of amyloid brain positron emission tomographic imaging in the diagnosis of Alzheimer disease is currently being formulated. The specificity of a positive amyloid scan is a matter of contention. OBSERVATIONS:An 83-year-old Canadian man presented with a 5-year history of predominantly short-...

    journal_title:JAMA neurology

    pub_type: 杂志文章

    doi:10.1001/jamaneurol.2013.420

    authors: Ducharme S,Guiot MC,Nikelski J,Chertkow H

    更新日期:2013-07-01 00:00:00